If enacted, SB141 would prompt the Secretary of Health and Human Services to submit a report to Congress within 18 months of the bill's enactment. This report would detail findings on current state practices, limitations, and barriers regarding device coverage, alongside recommendations aimed at overcoming these challenges. The intention is to actively transform Medicaid protocols to include these crucial devices, leading to more informed healthcare decisions and improved health outcomes for mothers and children navigating prenatal and postpartum phases.
Summary
SB141, known as the Connected Maternal Online Monitoring Act or Connected MOM Act, aims to identify and address barriers to the coverage of remote physiologic monitoring devices under State Medicaid programs. The bill specifically targets improving maternal and child health outcomes for pregnant and postpartum women by facilitating better monitoring through approved medical devices such as pulse oximeters, blood pressure cuffs, scales, and blood glucose monitors. Through comprehensive reporting and updates to state resources, the bill anticipates fostering innovations that could enhance healthcare delivery among this vulnerable demographic.
Contention
While supporters of SB141 champion this legislation as essential for advancing maternal health strategies and integrating technology into healthcare, there may be concerns from different stakeholders about the feasibility of widespread implementation across state lines. Disparities in state Medicaid systems may lead to unequal access to these devices, potentially exacerbating existing health inequities. Furthermore, critics might argue about the cost implications and implementation logistics for states as they adapt to new coverage requirements, raising questions over sustainable healthcare funding in the long term.
Establishes a maternal health monitoring pilot program within the department of health to offer eligible participants improved maternal health care through remote patient monitoring for maternal hypertension and maternal diabetes; requires delivery of a report.